Cargando…
地西他滨在糖皮质激素治疗失败原发免疫性血小板减少症患者中的疗效及影响因素
OBJECTIVE: This study aimed to evaluate the efficacy of decitabine(DAC)and identify factors influencing treatment responses in patients with primary immune thrombocytopenia(ITP)who had failed glucocorticoid therapy. METHODS: Clinical data of 61 patients with glucocorticoid-resistant ITP who received...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509621/ https://www.ncbi.nlm.nih.gov/pubmed/37749037 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.07.008 |
Ejemplares similares
-
我如何治疗糖皮质激素无效或复发的成人原发免疫性血小板减少症
Publicado: (2017) -
地西他滨治疗骨髓增生异常综合征及相关肿瘤的疗效预测因素研究
Publicado: (2017) -
地西他滨对K562细胞增殖和TFPI-2基因表达的影响
Publicado: (2017) -
硼替佐米、糖皮质激素为基础的联合方案治疗6例复发/难治免疫性血栓性血小板减少性紫癜
Publicado: (2023) -
SKM-1细胞地西他滨耐药机制中hENT1功能的研究
Publicado: (2015)